Bibliography
Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration. AIDS. 2012 ;26(7):890-3.
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1. Antimicrob Agents Chemother. 2010 ;54(12):5156-60.
Therapeutic amprenavir concentrations in cerebrospinal fluid. Antimicrob Agents Chemother. 2012 ;56(4):1985-9.
CD68 and HIV P24 expression in CNS and visceral tissues in HIV associated PML. In: Journal of NeuroVirology. Vol. 9. Journal of NeuroVirology. ; 2003. pp. 99-100.
. CD68 positive cells in the CNS of HIV1/PML patients express CD16 and KI67 but few cells express CD14. Evidence for expansion of the resident microglial population. In: Journal of NeuroVirology. Vol. 10. Journal of NeuroVirology. ; 2004. pp. 66-67.
. PCNA expression but lack of proliferation in CNS cells in HIVE: Evidence for the role of circulating monocyte/macrophages in CNS invasion and reservoir of HIV infection. In: Journal of Neuropathology and Experimental Neurology. Vol. 62. 5th ed. Journal of Neuropathology and Experimental Neurology. ; 2003. p. 539.
. The National NeuroAIDS Tissue Consortium (NNTC) Database: an integrated database for HIV-related studies. Database (Oxford). 2015 ;2015:bav074.
. Efavirenz Is Predicted To Accumulate in Brain Tissue: an In Silico, In Vitro, and In Vivo Investigation. Antimicrob Agents Chemother. 2017 ;61(1).
. Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change. J Clin Exp Neuropsychol. 2011 ;33(5):505-22.
JC virus granule cell neuronopathy is associated with VP1 C terminus mutants. Journal of General Virology [Internet]. 2012 ;93(Pt. 1):175-183. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21940415
. Cognitive Trajectory Phenotypes in Human Immunodeficiency Virus-Infected Patients. J Acquir Immune Defic Syndr. 2019 ;82(1):61-70.
. Variable patterns of neuropsychological performance in HIV-1 infection. Journal of Clinical and Experimental Neuropsychology [Internet]. 2008 ;30:613-26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18608689
. Whole transcriptome sequencing enables discovery and analysis of viruses in archived primary central nervous system lymphomas. PLoS One. 2013 ;8(9):e73956.
. Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. Journal of the National Cancer Institute [Internet]. 2002 ;94(4):267-273. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11854388
. Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. Journal of Neurovirology [Internet]. 2000 ;6(3):221-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10878711
. Association of Plasma Eicosanoid Levels With Immune, Viral, and Cognitive Outcomes in People With HIV. Neurology. 2022 ;99(12):e1251-e1264.
. Epigenetic alterations in the brain associated with HIV-1 infection and methamphetamine dependence. PLoS One. 2014 ;9(7):e102555.
. Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology. 2013 ;80(15):1415-23.
. Antiretroviral Penetration across Three Preclinical Animal Models and Humans in Eight Putative HIV Viral Reservoirs. Antimicrob Agents Chemother. 2019 ;64(1).
Antiretroviral Penetration and Drug Transporter Concentrations in the Spleens of Three Preclinical Animal Models and Humans. Antimicrob Agents Chemother. 2020 ;64(10).
Differing roles of autophagy in HIV-associated neurocognitive impairment and encephalitis with implications for morphine co-exposure. Front Microbiol. 2015 ;6:653.
. Differential expression of the alternatively spliced OPRM1 isoform μ-opioid receptor-1K in HIV-infected individuals. AIDS. 2014 ;28(1):19-30.
B-Adrenergic receptor gene expression in HIV-associate neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization. Journal of Neurovirology. 2016 .
. Differential expression and HIV-1 regulation of μ-opioid receptor splice variants across human central nervous system cell types. Journal of NeuroVirology [Internet]. 2012 ;18(3):181-190. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22528479
. .